Ofatumumab subcutaneous injection promising treatment option for refractory pemphigus vulgaris: Study Medha Baranwal4 March 2024 2:00 AM ISTChina: A recent study published in The Journal of Dermatology has suggested ofatumumab to be a promising treatment option for patients with refractory...
Clarifying Connection Between Whey Protein and Acne: Findings from Six-Month Trial Dr.Niharika Harsha B2 March 2024 3:45 AM ISTThe longstanding debate on whether whey protein consumption exacerbates acne vulgaris (AV) has taken a significant step forward with the results of a...
Rilzabrutinib effective and safe against chronic spontaneous urticaria, finds study Jacinthlyn Sylvia1 March 2024 12:15 AM ISTA recent study published in the Journal of Allergy and Clinical Immunology unveiled promising results from a Phase 2 study evaluating the efficacy and...
Exclusive breastfeeding for four months protects against psoriasis development through early adulthood: Study Medha Baranwal29 Feb 2024 12:30 AM ISTSweden: A recent study published in the British Journal of Dermatology for the first time has highlighted the potential role of early diet on...
Breakthrough Treatment for Polymorphic Light Eruption: Tofacitinib Shows Promise in Resistant Cases Dr.Niharika Harsha B27 Feb 2024 10:15 PM ISTA recent study has unveiled promising results for individuals suffering from polymorphous light eruption (PMLE), a sun-induced skin condition...
Liquid synthetic detergents good option for Atopic Dermatitis patients Aditi27 Feb 2024 5:45 AM ISTLiquid synthetic detergents are often acidic, making them suitable for individuals with atopic dermatitis. According to new research presented at the...
Botulinum toxin useful therapeutic option to improve cutaneous flushing, finds study Dr Riya Dave25 Feb 2024 11:00 PM ISTCutaneous flushing is a common dermatologic concern often resistant to conventional treatments.Oral medication or light-based therapies including...
Bristol Myers Squibb, Immunocore Holdings ink pact to evaluate IMC-F106C, nivolumab combo in registrational Phase 3 first-line advanced cutaneous melanoma trial Ruchika Sharma25 Feb 2024 2:00 PM ISTOxfordshire: Immunocore Holdings plc, a commercial-stage biotechnology company has announced that it has entered into a clinical trial...
Increased retinal detachment risk observed among vitiligo patients: Study Jacinthlyn Sylvia24 Feb 2024 1:30 AM ISTVitiligo is a condition characterized by the loss of skin pigment and has long been known to be associated majorly with various ocular abnormalities....
FDA approves Amtagavi for treatment of Advanced melanoma Dr. Kamal Kant Kohli22 Feb 2024 7:00 PM ISTThe US Food and Drug Administration has approved first cellular therapy Amtagavi for treatment of Advanced melanoma. It is one-time cell therapy for...
Study emphasizes vitamin D supplementation for all congenital melanocytic nevi patients during the winter months Medha Baranwal22 Feb 2024 4:45 AM ISTUK: A recent study published in Pediatric Dermatology supports routine vitamin D supplementation for all congenital melanocytic nevi (CMN) patients,...
Crisaborole may significantly improve stasis dermatitis, finds innovative study Dr. Shravani Dali21 Feb 2024 7:30 AM ISTCrisaborole may significantly improve stasis dermatitis, finds aninnovative study published in the Journal of the American Academy of...
